TIG Analyst Raises BrightSpring (BTSG) PT to $55, Cites Consistent Operational Performance

Core Viewpoint - BrightSpring Health Services Inc. (NASDAQ:BTSG) is identified as a strong IPO stock with positive analyst ratings and price target increases, reflecting confidence in its operational performance and growth potential [1][2][3]. Analyst Ratings and Price Targets - BTIG analyst David Larsen raised the price target for BrightSpring Health to $55 from $50, maintaining a Buy rating, highlighting the company's consistent performance across market cycles [1]. - TD Cowen analyst Charles Rhyee increased the price target to $46 from $42, also with a Buy rating, noting the company's expected momentum due to strong trends in specialty generics [2]. - BMO Capital raised its price target to $46 from $40 with an Outperform rating, emphasizing strong pharmaceutical relationships and competitive positioning in the specialty business [3]. Company Overview - BrightSpring Health Services operates as a home and community-based healthcare services platform in the US, divided into two segments: Pharmacy Solutions and Provider Services [4].